Your SAFE Notes Are Quietly Eating 28% of Your Cap Table

Post-money Simple Agreements for Future Equity (SAFEs) are the standard fundraising instrument in Silicon Valley today. They are fast, clean, and cheap to document.

They also harbor a hidden trap that blindsides founders and early angels alike.

Here is what happens in the wild. A founder raises $500,000 on a $6 million valuation cap. Three months later, momentum picks up, so they take another $750,000 on an $8 million cap. A month after that, they add another $500,000 on a $10 million cap.

It feels like easy money. But because each SAFE is post-money, the dilution stacks mathematically against the common shareholders.

When the lead institutional VC arrives for the Series A priced round, the founder models the cap table for the first time. They discover that the open SAFEs already sold 27.5% of the company. Add the incoming Series A VC's 20% target ownership and a fresh 10% option pool, and the founding team is left owning barely 42%.

The Angel Allocator's Defense

When you back an early-stage company, do not just sign the SAFE and hope for the best:

• Demand a Master Pro-Forma: Require the founder to show the total dollar amount of all outstanding unexercised SAFEs and convertible notes.
• Cap Pre-Series A Dilution at 20%: If a seed company sells more than 20% to 22% before Series A, the founders risk becoming unmotivated employees in their own business.
• Secure Pro-Rata Side Letters: Always secure written pro-rata rights so you can write a follow-on check to maintain your percentage ownership when the priced round happens.

Disciplined venture investing means protecting the founder's ownership just as aggressively as your own.